$ANIX 90 DAYS STOCK PRICE FORECAST
Stock Price
About the Company
Anixa Biosciences Inc. is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. The company's vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
Similar Companies
| Name | Ticker | Market Capitalization (USD M) | Revenue (USD M) | Price/Book | Price/Earning | Net Margin (%) |
|---|---|---|---|---|---|---|
| Hewlett Packard Enterprise Co | HPE | 21308 | 27912 | 1.02 | 5.71 | 13.32 |
| Western Digital Corp. | WDC | 19275 | 19185 | 1.60 | 10.55 | 9.49 |
| Seagate Technology Holdings Pl | STX | 19175 | 12046 | 42.91 | 10.38 | 15.40 |
| Netapp Inc | NTAP | 16923 | 6193 | 18.66 | 16.68 | 16.34 |
| Pure Storage Inc | PSTG | 7313 | 2181 | 10.11 | -51.14 | -6.57 |
| NCR Corp. | NCR | 4657 | 7478 | 3.46 | 304.55 | 0.23 |
| BlackBerry Ltd | BB | 3792 | 718 | 2.23 | -19.39 | 1.67 |
| Corsair Gaming Inc | CRSR | 1600 | 1904 | 2.68 | 15.84 | 5.30 |
| 3D Systems Corp. | DDD | 1356 | 616 | 1.67 | 4.22 | 52.31 |
| Avid Technology, Inc. | AVID | 1105 | 416 | -8.31 | 23.56 | 11.43 |
| Charge Enterprises Inc | CRGE | 850 | 477 | 57.75 | -12.16 | -12.38 |
| Cantaloupe Inc | USAT | 778 | 151 | 9.35 | -25.33 | -20.47 |
| CompoSecure Inc | CMPO | 667 | 268 | -0.10 | 50.14 | 5.04 |
| Eastman Kodak Co. | KODK | 590 | 1105 | 4.31 | -1.08 | -37.01 |
| Cantaloupe Inc | CTLP | 318 | 189 | 2.11 | -227.00 | -0.86 |
| Diebold Nixdorf Inc | DBD | 248 | 3905 | -0.30 | -3.15 | -2.02 |
| CPI Card Group Inc | PMTS | 206 | 397 | -1.69 | 10.34 | 4.91 |
| Immersion Corp | IMMR | 178 | 35 | 1.32 | 14.28 | 35.58 |
| Intevac, Inc. | IVAC | 129 | 34 | 1.03 | 4.96 | 74.91 |
| 9 Meters Biopharma Inc | NMTR | 113 | 2 | 2.90 | -3.09 | -468.45 |
| Anixa Biosciences Inc | ANIX | 102 | 0 | 3.01 | -6.94 | -14.90 |
| Quantum Corp | QMCO | 101 | 370 | -1.32 | -2.25 | -11.33 |
| One Stop Systems Inc | OSS | 89 | 62 | 2.01 | 37.17 | 3.76 |
| AstroNova Inc | ALOT | 87 | 117 | 1.12 | 14.11 | 5.47 |
| Transact Technologies Inc. | TACT | 44 | 39 | 1.25 | -10.89 | -10.52 |
| Datasea Inc | DTSS | 37 | 10 | 7.04 | -6.23 | -61.26 |
| U.S. Gold Corp | USAU | 32 | 17 | 1.89 | -2.61 | -14.13 |
| Borqs Technologies Inc | BRQS | 21 | 30 | -1.58 | -0.37 | -188.98 |
| Sonim Technologies Inc | SONM | 5 | 55 | 0.56 | -0.13 | -70.78 |
Anixa Biosciences (NASDAQ:ANIX) Cut to Hold at Zacks Investment Research
Anixa Biosciences (NASDAQ:ANIX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports.
Has Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year?
F or those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is ANIXA BIOSCIENCES INC (ANIX) one of tho ...
Anixa Biosciences, Inc.(ANIX)
Primary metrics and data points about Anixa Biosciences, Inc..
Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
SAN JOSE, Calif., May 5, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...
Anixa Biosciences Inc - Stock Analysis CY71
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
It indicates, "Click to perform a search". SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention ...
Has Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year?
Is ANIXA BIOSCIENCES INC (ANIX) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this ...
Anixa Biosciences Inc - Stock Sustainability ANIX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases ...